Related Experiment Video
Updated: May 28, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Reduced miR-193a-3p Modulates Cell Proliferation and Apoptosis in Inflammatory Bowel Disease via Targeting ETS1
Hailin Cheng1, Lei Xiao2, Tao Xu3
1Department of Gastroenterology, Wuhan Jinyintan Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
Background:
Multiple findings have demonstrated that microRNAs (miRNAs) have a profound impact on inflammatory bowel disease (IBD) pathogenesis. This research was conceived to elucidate the regulatory function of miR-193a-3p in IBDby targeting ETS proto‑oncogene 1 and explore its potential diagnostic value.
Methods:
Expression of miR-193a-3p was determined by reverse transcription quantitative real‑time polymerase-chain reaction (RT‑qPCR). Cell viability, apoptosis, and inflammatory responses were measured in lipopolysaccharide (LPS)-stimulated human normal colonic epithelial FHC cells using the cell counting kit‑8 (CCK‑8) assay, flow cytometry, and enzyme‑linked immunosorbent assay (ELISA), respectively. The dual-luciferase reporter's assay verified the targeting relationship.
Results:
miR-193a-3p was downregulated whereas ETS1 was upregulated in patients with inflammatory bowel disease (IBD). Its expression was negatively correlated with IBD severity in both ulcerative colitis (UC) and Crohn's disease (CD). In vitro, elevated miR-193a-3p alleviated LPS-induced inflammation and apoptosis and promoted cell proliferation. A negative regulatory relationship between miR-193a-3p and ETS1 was validated experimentally. miR-193a-3p overexpression inhibited LPS-mediated upregulation of ETS1. In addition, ETS1 overexpression suppressed cell proliferation and facilitated inflammation and cell apoptosis.
Conclusion:
miR-193a-3p was involved in the pathogenesis of IBD by directly targeting ETS1.
Insights
MicroRNA-193a-3p is downregulated in inflammatory bowel disease (IBD), impacting disease severity. This study shows miR-193a-3p targets ETS1, suggesting its diagnostic potential for IBD.
Area of Science:
- Gastroenterology
- Molecular Biology
- Immunology
Background:
- MicroRNAs (miRNAs) play a crucial role in the pathogenesis of inflammatory bowel disease (IBD).
- Understanding specific miRNA roles, like miR-193a-3p, is vital for IBD research.
- ETS proto-oncogene 1 (ETS1) is implicated in cellular processes relevant to IBD.
Purpose of the Study:
- To investigate the regulatory function of miR-193a-3p in IBD pathogenesis.
- To determine if miR-193a-3p targets ETS proto-oncogene 1 (ETS1).
- To explore the potential diagnostic value of miR-193a-3p in IBD.
Main Methods:
- Quantitative real-time PCR (RT-qPCR) for miRNA expression analysis.
- Cell-based assays (CCK-8, flow cytometry, ELISA) to assess cell viability, apoptosis, and inflammation.
- Dual-luciferase reporter assay to validate the targeting relationship between miR-193a-3p and ETS1.
Main Results:
- miR-193a-3p was downregulated in IBD patients (ulcerative colitis and Crohn's disease) and negatively correlated with disease severity.
- Overexpression of miR-193a-3p reduced inflammation and apoptosis while promoting proliferation in LPS-stimulated cells.
- Experimental validation confirmed a direct targeting relationship where miR-193a-3p suppresses ETS1 expression.
Conclusions:
- miR-193a-3p is involved in IBD pathogenesis through direct targeting of ETS1.
- Modulation of miR-193a-3p may represent a therapeutic strategy for IBD.
- miR-193a-3p holds potential as a diagnostic biomarker for IBD.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
MicroRNAs
MicroRNAs
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Abnormal Proliferation
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
